Literature DB >> 19177577

Chemokines in the immunopathogenesis of hepatitis C infection.

Mathis Heydtmann1, David H Adams.   

Abstract

Chronic infection with the hepatitis C virus, a noncytopathic hepatotropic RNA virus, affects over 170 million people worldwide. In the majority of cases, neither the early innate immune response nor the later adaptive immune response succeeds in clearing the virus, and the infection becomes chronic. Furthermore, in many patients, the ineffective inflammatory response drives fibrogenesis and the development of cirrhosis. It is critical to understand this immune pathology if preventative and curative therapies are to be developed. Chemokines are a superfamily of small proteins that promote leukocyte migration and orchestrate the immune response to viruses, including hepatitis C virus. Chemokines are crucial for viral elimination, but inappropriate persistence of expression in chronic hepatitis C infection can drive tissue damage and inflammation. Here we review the role of chemokines and their receptors in hepatitis C virus infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19177577      PMCID: PMC2919201          DOI: 10.1002/hep.22763

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  104 in total

1.  Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes.

Authors:  A Bonacchi; P Romagnani; R G Romanelli; E Efsen; F Annunziato; L Lasagni; M Francalanci; M Serio; G Laffi; M Pinzani; P Gentilini; F Marra
Journal:  J Biol Chem       Date:  2001-01-02       Impact factor: 5.157

2.  Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants.

Authors:  S Goddard; A Williams; C Morland; S Qin; R Gladue; S G Hubscher; D H Adams
Journal:  Transplantation       Date:  2001-12-27       Impact factor: 4.939

Review 3.  Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells.

Authors:  P A Knolle; A Limmer
Journal:  Trends Immunol       Date:  2001-08       Impact factor: 16.687

Review 4.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

5.  CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.

Authors:  R F Schwabe; B Schnabl; Y O Kweon; D A Brenner
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

6.  Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.

Authors:  Rainer P Woitas; Golo Ahlenstiel; Agathe Iwan; Jürgen K Rockstroh; Hans H Brackmann; Bernd Kupfer; Bertfried Matz; Ruth Offergeld; Tilman Sauerbruch; Ulrich Spengler
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

Review 7.  Noncytolytic control of viral infections by the innate and adaptive immune response.

Authors:  L G Guidotti; F V Chisari
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

8.  Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy.

Authors:  S J Polyak; K S Khabar; M Rezeiq; D R Gretch
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

9.  Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.

Authors:  Allister J Grant; Sarah Goddard; Jalal Ahmed-Choudhury; Gary Reynolds; David G Jackson; Michael Briskin; Lijun Wu; Stefan G Hübscher; David H Adams
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

10.  Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease.

Authors:  H Yoneyama; K Matsuno; Y Zhang; M Murai; M Itakura; S Ishikawa; G Hasegawa; M Naito; H Asakura; K Matsushima
Journal:  J Exp Med       Date:  2001-01-01       Impact factor: 14.307

View more
  56 in total

Review 1.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

2.  The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes.

Authors:  Joan Oliva; Fawzia Bardag-Gorce; Andrew Lin; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2010-04-28       Impact factor: 3.362

Review 3.  The role of chemokines in the recruitment of lymphocytes to the liver.

Authors:  Ye H Oo; Shishir Shetty; David H Adams
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

4.  Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway.

Authors:  Benting Ma; Junjie Zhu; Juan Tan; Yulei Mao; Lingyun Tang; Chunling Shen; Hongxing Zhang; Ying Kuang; Jian Fei; Xiao Yang; Zhugang Wang
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

5.  Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway.

Authors:  Todd Bartkowiak; Ashvin R Jaiswal; Casey R Ager; Renee Chin; Chao-Hsien Chen; Pratha Budhani; Midan Ai; Matthew J Reilley; Manu M Sebastian; David S Hong; Michael A Curran
Journal:  Clin Cancer Res       Date:  2018-01-04       Impact factor: 12.531

6.  Leveraging the biology of adversity to address the roots of disparities in health and development.

Authors:  Jack P Shonkoff
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

7.  Frontline Science: c-Myc regulates P-selectin glycoprotein ligand-1 expression in monocytes during HIV-1 infection.

Authors:  Ryan Connor; Letitia D Jones; Xing Qiu; Juilee Thakar; Sanjay B Maggirwar
Journal:  J Leukoc Biol       Date:  2017-06-29       Impact factor: 4.962

Review 8.  Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer.

Authors:  Jessica Brownell; Stephen J Polyak
Journal:  Clin Cancer Res       Date:  2013-01-15       Impact factor: 12.531

9.  Impaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virus.

Authors:  Feng Qian; Christopher R Bolen; Chunxia Jing; Xiaomei Wang; Wei Zheng; Hongyu Zhao; Erol Fikrig; R Douglas Bruce; Steven H Kleinstein; Ruth R Montgomery
Journal:  Clin Vaccine Immunol       Date:  2012-12-05

10.  CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis.

Authors:  Shinji Shimoda; Kenichi Harada; Hiroaki Niiro; Akinobu Taketomi; Yoshihiko Maehara; Koichi Tsuneyama; Kentaro Kikuchi; Yasuni Nakanuma; Ian R Mackay; M Eric Gershwin; Koichi Akashi
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.